Equity
€130,256 ▲ 7.9%
RX DM paid out €55,000 in dividends. That is 85% of the 2025 profit.
RX DM
Lifetime
7 annual accounts with figures on one time axispeak €131,040 (2021)
€127,963▲ 15.2%
peak €64,528 (2025)
€64,528▲ 27.1%
peak €149,489 (2021)
€130,256▲ 7.9%
€59,490▲ 5.3%
Board1 name since 2019
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €111,090 to €127,963Result from €50,788 to €64,528Dividend €55,000Cash from €90,102 to €58,374
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as RX DM has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for RX DM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0722787085
Resignation: (manager and director)
Reappointment: (director) · Director discharge: · Gazette deed
Incorporation
Founding capital of €18,600, 100 shares · Founder: · Appointment: (manager) · published on 19-03-2019 · Gazette deed
First establishment
Kerselaarstraat 8, Dilbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| RX DM Dilbeek | €189,746 | €127,963 | 68.6% | - |
| OPHTA-FLORES Watermael-Boitsfort | €181,164 | €123,295 | 12.0% | - |
| Dokter Leen Vandenbussche, Psychiater Kruisem | €182,894 | €130,421 | 90.1% | - |
| TRINITY HML ANESTHESIE Oudsbergen | €187,634 | €117,668 | 45.5% | - |
| DR STEPHANIE COLLET Rixensart | €186,848 | €141,454 | 76.3% | - |
| Neuronlogica Boom | €207,486 | €117,092 | 33.5% | - |
| JV Cardiologie Wavre | €211,253 | €129,472 | 31.5% | - |
These companies have the same main activity as RX DM: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €181,000 and €211,000, founded between 2019 and 2020.
Official details
Source: KBO- Status
- Active since 15-03-2019Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.286.579.9111700 Dilbeek, since 15-03-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 27-11-2025
Annual accounts 2025
- €189,746▲ 7.1%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on RX DM
RX DM files the micro format. That format states no turnover. The gross margin rose from €76,722 in 2019 to €127,963 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about RX DM
- What is the company number of RX DM?
- The company number of RX DM is 0722.787.085. The VAT number is the same number with BE in front: BE 0722.787.085.
- Where is RX DM based?
- The registered office is at Kerselaarstraat 8, 1700 Dilbeek.Company details
- What does RX DM do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of RX DM?
- RX DM is a private limited company (BV).
- When was RX DM founded?
- RX DM was founded on 15-03-2019.
- Is RX DM still active?
- Yes, RX DM is an active enterprise in the KBO register.
- What is the turnover of RX DM?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €127,963 and 40 comparable companies (NACE 86220). It probably lies between €200,000 and €320,000.Financials
- Is RX DM profitable?
- In financial year 2025, RX DM made a profit of €64,528.
- Where can I find the annual accounts of RX DM?
- RX DM filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of RX DM due?
- RX DM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.